News
Pfizer Inc. (NYSE: PFE) reported financial results for the second quarter of 2025 and reaffirmed its 2025 Revenue guidance while raising guidance(1) for Adjusted(2) diluted EPS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback